These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2726871)

  • 1. Structure-activity studies of chemical carcinogens in non congeneric sets of compounds.
    Benigni R; Andreoli C; Giuliani A
    Prog Clin Biol Res; 1989; 291():349-52. PubMed ID: 2726871
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of structure generators in predictive pharmacology and toxicology.
    Wieland T
    Arzneimittelforschung; 1996 Feb; 46(2):223-7. PubMed ID: 8720320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology.
    Benigni R; Bossa C
    Mutat Res; 2008; 659(3):248-61. PubMed ID: 18621573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship analysis tools: validation and applicability in predicting carcinogens.
    Mayer J; Cheeseman MA; Twaroski ML
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):50-8. PubMed ID: 18023949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural databases and computer modeling in pharmaceutical research.
    Mueller K; Ammann HJ; Doran DM; Gerber PR; Gubernator K; Schrepfer G
    Prog Clin Biol Res; 1989; 291():219-26. PubMed ID: 2726850
    [No Abstract]   [Full Text] [Related]  

  • 6. DARC/PELCO success in anticholinergic research.
    Mercier C; Trouiller G
    Prog Clin Biol Res; 1989; 291():203-7. PubMed ID: 2726847
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards a MIP-based alignment and docking in computer-aided drug design.
    Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J
    Proteins; 2004 Aug; 56(3):585-94. PubMed ID: 15229890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive toxicology: benchmarking molecular descriptors and statistical methods.
    Feng J; Lurati L; Ouyang H; Robinson T; Wang Y; Yuan S; Young SS
    J Chem Inf Comput Sci; 2003; 43(5):1463-70. PubMed ID: 14502479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.
    Cohen C; Fischel O; Cohen E
    Chem Biol Drug Des; 2007 Jan; 69(1):75-82. PubMed ID: 17313460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General purpose interactive physico-chemical property exploration.
    Smellie A
    J Chem Inf Model; 2007; 47(3):1182-7. PubMed ID: 17487961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ring systems in mutagenicity databases.
    Kho R; Hodges JA; Hansen MR; Villar HO
    J Med Chem; 2005 Oct; 48(21):6671-8. PubMed ID: 16220983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-aided rodent carcinogenicity prediction.
    Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
    Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR oriented computer representation of chemical compounds used in CISOC-SARSS.
    Yuan SG; Zhao X; Zeng FY; Zheng CZ
    Prog Clin Biol Res; 1989; 291():195-8. PubMed ID: 2726845
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-activity relationship analysis of rat mammary carcinogens.
    Cunningham AR; Moss ST; Iype SA; Qian G; Qamar S; Cunningham SL
    Chem Res Toxicol; 2008 Oct; 21(10):1970-82. PubMed ID: 18759503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random forest prediction of mutagenicity from empirical physicochemical descriptors.
    Zhang QY; Aires-de-Sousa J
    J Chem Inf Model; 2007; 47(1):1-8. PubMed ID: 17238242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DISE: directed sphere exclusion.
    Gobbi A; Lee ML
    J Chem Inf Comput Sci; 2003; 43(1):317-23. PubMed ID: 12546567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of structure-activity relationships in predicting carcinogenesis.
    Rosenkranz HS; Frierson MR; Klopman G
    IARC Sci Publ; 1986; (83):497-517. PubMed ID: 3305352
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Standard enthalpies of formation and carcinogenic activity.
    Subach DJ
    Health Phys; 1974 Oct; 27(4):403-4. PubMed ID: 4443284
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity models of chemical carcinogens: state of the art, and new directions.
    Benigni R; Bossa C
    Ann Ist Super Sanita; 2006; 42(2):118-26. PubMed ID: 17033131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.